|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Seroxat
|
|
gptkbp:approves
|
gptkb:1992
|
|
gptkbp:class
|
gptkb:selective_serotonin_reuptake_inhibitor_(SSRI)
|
|
gptkbp:contraindication
|
gptkb:healthcare_organization
liver disease
pregnancy
MAO inhibitors
|
|
gptkbp:dosage_form
|
20-50 mg daily
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Aropax
|
|
gptkbp:ingredients
|
gptkb:paroxetine
C19 H20 FN O3 S
|
|
gptkbp:interacts_with
|
gptkb:beer
blood thinners
other antidepressants
NSAI Ds
|
|
gptkbp:invention
|
gptkb:2003
|
|
gptkbp:is_atype_of
|
N06 A B05
|
|
gptkbp:is_available_on
|
gptkb:tablet
oral suspension
|
|
gptkbp:is_used_for
|
gptkb:historical_event
gptkb:post-traumatic_stress_disorder
anxiety disorders
obsessive-compulsive disorder
panic disorder
|
|
gptkbp:legal_issue
|
prescription only
|
|
gptkbp:lifespan
|
24 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:Glaxo_Smith_Kline
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:previous_name
|
paroxetine hydrochloride
|
|
gptkbp:rounds
|
urine
|
|
gptkbp:side_effect
|
nausea
drowsiness
insomnia
dry mouth
sexual dysfunction
|
|
gptkbp:symptoms
|
dizziness
nausea
sleep disturbances
irritability
|
|
gptkbp:traded_on
|
gptkb:Seroxat
gptkb:Paxil
|
|
gptkbp:type_of
|
61869-08-7
|
|
gptkbp:weight
|
365.43 g/mol
|
|
gptkbp:year_created
|
1970s
|